Vaccine News and Research

Latest Vaccine News and Research

LA hospital seeks vaccine trial participants among its own high-risk patients

The patients at Dr. Eric Daar's hospital are at high risk for serious illness from COVID-19, and he's determined to make sure they're part of the effort to fight the disease.

26 Aug 2020

BM32 vaccine against grass pollen allergy could be potential treatment for hepatitis B infection

Chronic hepatitis B infections represent a global health problem that could hitherto only be treated by chemotherapy.

26 Aug 2020

Study: COVID-19 vaccine should be at least 80% effective to prevent ongoing pandemic

The American Journal of Preventive Medicine, published by Elsevier, is committed to publishing the most robust, evidence-based research and commentary on COVID-19 as they unfold to keep readers up to date and aware of issues relevant to community and individual health during this continually evolving global outbreak.

26 Aug 2020

Monoclonal antibodies may be a better choice than convalescent plasma for treating COVID-19

A team of researchers from the Netherlands demonstrated that prophylactic treatment with a high dose of human convalescent plasma or by using concentrated monoclonal antibodies could protect against disease following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in an animal model. However, no protective effect was observed with a ten-fold lower dose of convalescent plasma. The results are currently available on the bioRxiv* preprint server.

25 Aug 2020

Study finds an increase in fake posts on social media tied to COVID-19

During the SARS-CoV-2 pandemic, social media platforms have played a major role in conveying information from health care leaders and government officials to communities about how to help stop the spread of COVID-19.

25 Aug 2020

Preclinical studies of a COVID-19 vaccine candidate show positive results

Preclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show positive results that appear to distinguish this vaccine candidate from other vaccine candidates that are currently in advanced stages of clinical development, the Maryland-based Altimmune Inc. announced today.

25 Aug 2020

Hydroxychloroquine treatment for COVID-19 patients lowers in-hospital mortality rates

An Italian observational study contributes to the ongoing debate regarding the use of hydroxychloroquine in the current pandemic.

25 Aug 2020

Inconsistent implementation of COVID-19 control has dire consequences

Researchers in the United States have conducted a study highlighting the potential unintended consequences of implementing coronavirus disease 2019 (COVID-19) control policies in an inconsistent, patchy manner.

25 Aug 2020

Study tracks the mutation rate of SARS-Cov-2 virus

Since COVID-19 began its menacing march across Wuhan, China, in December 2019, and then across the world, the SARS-CoV-2 virus has taken a "whatever works" strategy to ensure its replication and spread.

25 Aug 2020

Italy starts human trials of potential COVID-19 vaccine

Rome's Lazzaro Spallanzani Institute, a hospital specializing in infectious diseases will conduct trials on 90 volunteers in the coming weeks, joining a global effort to develop an immune response to the virus.

25 Aug 2020

Higher COVID-19 risk perception among older American adults

In a new study published on the preprint server medRxiv*, researchers from the Yale Institute for Global Health analyzed the shift in COVID-19 risk perception, behavior, knowledge, and attitude across the U.S. from February to May 2020 by surveying 672 adults.

25 Aug 2020

Government response to COVID-19 influences citizens' adherence to social distancing measures

A new study conducted by a team of researchers, including University of Colorado Denver Business School associate professor Jiban Khuntia, Ph.D., found while social distancing is an effective preventative measure in the fight against COVID-19, there are significant variations being observed in how and why individuals follow the restrictions.

25 Aug 2020

COVID specific IgA monoclonal antibodies may provide effective immunity against coronavirus

A new study by researchers at MassBiologics of UMass Medical School published in Nature Communications suggests that COVID specific IgA monoclonal antibodies may provide effective immunity in the respiratory system against the novel coronavirus - a potentially critical feature of an effective vaccine.

25 Aug 2020

Health experts provide guidelines on scientific investigation of synbiotics

Chances are you've heard of or even taken probiotics: supplements delivering "good microbes" to the gut, providing a wide range of health benefits. If you're really up on your gut health, you may also be aware of prebiotics: supplements designed to fuel the good microbes already living in our guts.

25 Aug 2020

World's first confirmed case of SARS-CoV-2 re-infection

A team of researchers at the University of Hong Kong said that they have proven that a 33-year-old man was infected by the SARS-CoV-2 virus for a second time. The man was discharged from a hospital in April but contracted the infection again after returning from Spain via the United Kingdom in August.

24 Aug 2020

Single dose nasal vaccine against SARS-CoV-2 shows promise in animal studies

Now researchers at the Washington University School of Medicine in St. Louis have worked on developing a candidate vaccine against the infection that could be administered in a single dose via a nasal spray rather than an injection. In their preliminary studies using lab mice, this single dose of the nasal vaccine successfully prevented the infection with the novel coronavirus.

24 Aug 2020

Sociopaths less likely to comply with COVID mask, hygiene and social distancing

Now, a new study by researchers from Brazil has found that people who are unconcerned with adhering to measures to mitigate the COVID-19 spread tend to manifest higher levels of traits tied to antisocial personality disorder, which is also known as sociopathy.

24 Aug 2020